πŸ‡ΊπŸ‡Έ FDA
Patent

US 9415008

Dry powder inhaler

granted A61KA61K31/137A61K31/138

Quick answer

US patent 9415008 (Dry powder inhaler) held by Teva Branded Pharmaceutical Products R&D, Inc. expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Teva Branded Pharmaceutical Products R&D, Inc.
Grant date
Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/137, A61K31/138, A61K31/56, A61K47/26